Mitigating early development risks with Samsung Biologics DEVELOPICK™ platform

Early identification of promising drug candidates is critical for safe and efficient development. In our latest whitepaper, Heonchang Lim, Director of Formulation Development, explains how we leverage our proprietary DEVELOPICK™ platform to streamline the discovery process, enhancing the likelihood of successful drug commercialization.

Early identification of promising drug candidates is critical for safe and efficient development. In our latest whitepaper, Heonchang Lim, Director of Formulation Development, explains how we leverage our proprietary DEVELOPICK™ platform to streamline the discovery process, enhancing the likelihood of successful drug commercialization.